Skip to content

Pharma-Bio Serv, Inc.

PBSV

CIK 0001304161

← back to feed
Revenue (TTM)
$9.38M
−5.3% YoY Q2 Jun 2026
Net Income (TTM)
$156.95K
+87.1% YoY Q2 Jun 2026
EPS Diluted (TTM)
$0.02
+88.2% YoY Q2 Jun 2026
Gross Margin
32.2%
Q2 Jun 2026
Operating Margin
-3.9%
Q2 Jun 2026
Net Margin
1.7%
Q2 Jun 2026
Free Cash Flow (TTM)
−$831.54K
Q2 Jun 2026
Cash
$2.87M
Q2 Jun 2026
Total Debt
—
Q2 Jun 2026
Shares Outstanding
22.9M sh
Q2 Jun 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings